強(qiáng)化劑量阿托伐他汀對(duì)不穩(wěn)定型心絞痛患者PCI圍手術(shù)期B7-H3、B7-H4的影響
發(fā)布時(shí)間:2018-09-08 07:54
【摘要】:目的探討強(qiáng)化劑量阿托伐他汀對(duì)不穩(wěn)定型心絞痛患者經(jīng)皮冠狀動(dòng)脈介入治療(PCI)圍手術(shù)期B7-H3和B7-H4表達(dá)的影響。方法將80例不穩(wěn)定型心絞痛患者隨機(jī)分為常規(guī)劑量組(阿托伐他汀20 mg/d,n=40)和強(qiáng)化劑量組(阿托伐他汀80 mg/d,n=40),分別于PCI術(shù)前和術(shù)后18~24 h收集外周靜脈血,采用ELISA檢測(cè)外周血白細(xì)胞介素4(IL-4)、白細(xì)胞介素10(IL-10)、干擾素γ(IFN-γ)、血清可溶性B7-H3(sB7-H3)、可溶性B7-H4(sB7-H4)水平,用實(shí)時(shí)熒光定量PCR檢測(cè)外周血單核細(xì)胞B7-H3、B7-H4 mRNA相對(duì)表達(dá)量。結(jié)果兩組患者PCI術(shù)后IL-10、sB7-H3、sB7-H4水平和B7-H3、B7-H4的mRNA表達(dá)水平均較術(shù)前升高,其中強(qiáng)化劑量組升高更顯著(P0.05)。相反,兩組患者PCI術(shù)后IL-4、IFN-γ水平均降低,且強(qiáng)化劑量組較常規(guī)劑量組下降更明顯(P0.05)。結(jié)論強(qiáng)化劑量阿托伐他汀可能通過促進(jìn)B7-H3、B7-H4表達(dá),從而降低不穩(wěn)定型心絞痛患者PCI術(shù)后免疫炎癥反應(yīng)。
[Abstract]:Objective to investigate the effect of enhanced dose of Atto vastatin on the expression of B7-H3 and B7-H4 in patients with unstable angina pectoris undergoing percutaneous coronary intervention (PCI) in perioperative period of (PCI). Methods 80 patients with unstable angina pectoris were randomly divided into routine dose group (Atto vastatin 20 mg/d,n=40) and enhanced dose group (Atto vastatin 80 mg/d,n=40). Peripheral venous blood was collected before and after PCI at 1824 hours. The levels of interleukin-4 (IL-4), interleukin-10 (IL-10), interferon 緯 (IFN- 緯), serum soluble B7-H3 (sB7-H3) and soluble B7-H4 (sB7-H4) were detected by ELISA. The relative expression of B7-H3OB7-H4 mRNA in peripheral blood monocytes was detected by real-time fluorescence quantitative PCR. Results the levels of IL-10,sB7-H3,sB7-H4 and mRNA expression of B7-H _ 3 and B _ 7-H _ 4 after PCI in both groups were higher than those before operation, especially in the enhanced dose group (P0.05). On the contrary, the level of IL-4,IFN- 緯 decreased in both groups after PCI, and the level of IL-4,IFN- 緯 in the enhanced dose group was significantly lower than that in the conventional dose group (P0.05). Conclusion the enhanced dose of Atto vastatin may decrease the immune inflammation after PCI in patients with unstable angina pectoris by promoting the expression of B7-H _ 3 and B _ 7-H _ 4.
【作者單位】: 廣西醫(yī)科大學(xué)第一附屬醫(yī)院心血管內(nèi)科;廣西中醫(yī)藥大學(xué)第一附屬醫(yī)院中西醫(yī)結(jié)合心血管內(nèi)科;玉林市紅十字會(huì)醫(yī)院心血管內(nèi)科;益陽醫(yī)學(xué)高等?茖W(xué)校附屬醫(yī)院內(nèi)一科;永州市中心醫(yī)院心血管內(nèi)科;
【基金】:廣西科學(xué)研究與技術(shù)開發(fā)計(jì)劃項(xiàng)目(科技攻關(guān)1355005-4-6)
【分類號(hào)】:R541.4
[Abstract]:Objective to investigate the effect of enhanced dose of Atto vastatin on the expression of B7-H3 and B7-H4 in patients with unstable angina pectoris undergoing percutaneous coronary intervention (PCI) in perioperative period of (PCI). Methods 80 patients with unstable angina pectoris were randomly divided into routine dose group (Atto vastatin 20 mg/d,n=40) and enhanced dose group (Atto vastatin 80 mg/d,n=40). Peripheral venous blood was collected before and after PCI at 1824 hours. The levels of interleukin-4 (IL-4), interleukin-10 (IL-10), interferon 緯 (IFN- 緯), serum soluble B7-H3 (sB7-H3) and soluble B7-H4 (sB7-H4) were detected by ELISA. The relative expression of B7-H3OB7-H4 mRNA in peripheral blood monocytes was detected by real-time fluorescence quantitative PCR. Results the levels of IL-10,sB7-H3,sB7-H4 and mRNA expression of B7-H _ 3 and B _ 7-H _ 4 after PCI in both groups were higher than those before operation, especially in the enhanced dose group (P0.05). On the contrary, the level of IL-4,IFN- 緯 decreased in both groups after PCI, and the level of IL-4,IFN- 緯 in the enhanced dose group was significantly lower than that in the conventional dose group (P0.05). Conclusion the enhanced dose of Atto vastatin may decrease the immune inflammation after PCI in patients with unstable angina pectoris by promoting the expression of B7-H _ 3 and B _ 7-H _ 4.
【作者單位】: 廣西醫(yī)科大學(xué)第一附屬醫(yī)院心血管內(nèi)科;廣西中醫(yī)藥大學(xué)第一附屬醫(yī)院中西醫(yī)結(jié)合心血管內(nèi)科;玉林市紅十字會(huì)醫(yī)院心血管內(nèi)科;益陽醫(yī)學(xué)高等?茖W(xué)校附屬醫(yī)院內(nèi)一科;永州市中心醫(yī)院心血管內(nèi)科;
【基金】:廣西科學(xué)研究與技術(shù)開發(fā)計(jì)劃項(xiàng)目(科技攻關(guān)1355005-4-6)
【分類號(hào)】:R541.4
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 鄧燕婕,李品飛,李宏偉;不穩(wěn)定型心絞痛的中西藥對(duì)照治療[J];實(shí)用中醫(yī)內(nèi)科雜志;2001年02期
2 潘龍峰;紫外線照射充氧自血回輸治療不穩(wěn)定型心絞痛療效觀察[J];浙江中西醫(yī)結(jié)合雜志;2001年08期
3 金鏢;不穩(wěn)定型心絞痛治療現(xiàn)狀[J];臨沂醫(yī)學(xué)?茖W(xué)校學(xué)報(bào);2002年04期
4 趙云霞 ,孟凡良 ,吉世軍;不穩(wěn)定型心絞痛48例臨床分析[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2002年05期
5 王國彬,胡申江,孫堅(jiān);不穩(wěn)定型心絞痛患者內(nèi)皮素及血管性假血友病因子的改變[J];浙江醫(yī)學(xué);2002年04期
6 紀(jì)宏斌;韓衛(wèi);商淑芹;;中西醫(yī)結(jié)合治療不穩(wěn)定型心絞痛的療效觀察[J];齊魯護(hù)理雜志;2002年06期
7 鄭桂琴,丁春賢,崔雨梅;克塞治療不穩(wěn)定型心絞痛56例療效觀察[J];吉林醫(yī)學(xué);2003年03期
8 黃s,
本文編號(hào):2229875
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2229875.html
最近更新
教材專著